Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Yamasa presents novel xanthine oxidase inhibitors

Jan. 22, 1998

Antiprogestational agents with reduced antiglucocorticoid activity claimed by HHS

Jan. 21, 1998

Duphar presents new vitamin D analogues

Jan. 21, 1998

BMS claims new beta3-adrenoceptor agonists

Jan. 21, 1998

BioTime lays groundwork for Japanese licensing of Hextend

Jan. 20, 1998

Filgrastim reduces neutropenia and morbidity associated with AML treatment

Jan. 20, 1998

Raloxifene launched in U.S.

Jan. 19, 1998

Lilly reports new benzothiophenes for gynecological and other disorders

Jan. 19, 1998

Merck subsidiary and Autogen collaborate on obesity research

Jan. 19, 1998

Takeda discloses compounds for cachexia

Jan. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...